Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial

dc.contributor.author	O'BYRNE, KEN	en
dc.date.accessioned	2018-02-27T13:38:40Z
dc.date.available	2018-02-27T13:38:40Z
dc.date.issued	2017	en
dc.date.submitted	2017	en
dc.identifier.citation	Ferry, D. and Billingham, L. and Jarrett, H. and Dunlop, D. and Woll, P.J. and Nicolson, M. and Shah, R. and Thompson, J. and Spicer, J. and Muthukumar, D. and Skailes, G. and Leonard, P. and Chetiyawardana, A.D. and Wells, P. and Lewanski, C. and Crosse, B. and Hill, M. and Gaunt, P. and O'Byrne, K., Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial, European Journal of Cancer, 83, 2017, 302-312	en
dc.identifier.other	Y	en
dc.description	PUBLISHED	en
dc.description	cited By 1	en
dc.format.extent	302-312	en
dc.relation.ispartofseries	European Journal of Cancer	en
dc.relation.ispartofseries	83	en
dc.rights	Y	en
dc.title	Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial	en
dc.type	Journal Article	en
dc.type.supercollection	scholarly_publications	en
dc.type.supercollection	refereed_publications	en
dc.identifier.peoplefinderurl	http://people.tcd.ie/obyrneke	en
dc.identifier.rssinternalid	184816	en
dc.identifier.doi	http://dx.doi.org/10.1016/j.ejca.2017.05.037	en
dc.rights.ecaccessrights	openAccess
dc.identifier.uri	http://hdl.handle.net/2262/82623

Browse